These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10025739)

  • 21. Cutaneous hyperpigmentation induced by doxycycline: histochemical and ultrastructural examination, laser microprobe mass analysis, and cathodoluminescence.
    Böhm M; Schmidt PF; Lödding B; Uphoff H; Westermann G; Luger TA; Bonsmann G; Metze D
    Am J Dermatopathol; 2002 Aug; 24(4):345-50. PubMed ID: 12142617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Minocycline-induced hyperpigmentation in multibacillary leprosy.
    Hu SW; Robinson MR; Newlove T; Meehan S; Levis WR; Patel RR
    Am J Dermatopathol; 2012 Dec; 34(8):e114-8. PubMed ID: 23169418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imipramine-associated hyperpigmentation.
    Dean CE; Grund FM
    Ann Pharmacother; 2003 Jun; 37(6):825-8. PubMed ID: 12773071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microprobe analysis of chlorpromazine pigmentation.
    Benning TL; McCormack KM; Ingram P; Kaplan DL; Shelburne JD
    Arch Dermatol; 1988 Oct; 124(10):1541-4. PubMed ID: 2844124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of panic disorder in older adults: a pilot study comparison of alprazolam, imipramine, and placebo.
    Sheikh JI; Swales PJ
    Int J Psychiatry Med; 1999; 29(1):107-17. PubMed ID: 10376237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Painful ejaculation associated with antidepressants in four patients.
    Aizenberg D; Zemishlany Z; Hermesh H; Karp L; Weizman A
    J Clin Psychiatry; 1991 Nov; 52(11):461-3. PubMed ID: 1744063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic dizziness presenting in a patient with panic disorder: response to imipramine.
    Mezzasalma MA; Mathias Kde V; Nascimento I; Valença AM; Nardi AE
    Arq Neuropsiquiatr; 2009 Mar; 67(1):121-2. PubMed ID: 19330229
    [No Abstract]   [Full Text] [Related]  

  • 28. Imipramine on the treatment of chronic dizziness and panic disorder--3 cases report.
    Mezzasalma MA; Mathias Kde V; Nascimento I; Valença AM; Nardi AE
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 May; 34(4):717-8. PubMed ID: 20307620
    [No Abstract]   [Full Text] [Related]  

  • 29. Cutaneous hyperpigmentation induced by omeprazole mimicking ashy dermatosis.
    Ramírez-Hernández M; Martínez-Escribano JA; Martínez-Barba E; Alcolea-Rubio LA; Ibarra-Berrocal IJ
    J Eur Acad Dermatol Venereol; 2006 May; 20(5):584-7. PubMed ID: 16684288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adrenergic receptor function in panic disorder. I. Platelet alpha 2 receptors: Gi protein coupling, effects of imipramine, and relationship to treatment outcome.
    Gurguis GN; Antai-Otong D; Vo SP; Blakeley JE; Orsulak PJ; Petty F; Rush AJ
    Neuropsychopharmacology; 1999 Feb; 20(2):162-76. PubMed ID: 9885796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interstitial lung disease probably caused by imipramine.
    Deshpande PR; Ravi R; Gouda S; Stanley W; Hande MH
    Am J Ther; 2014; 21(2):e66-8. PubMed ID: 22960847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A boost for St. John's Wort?
    Health News; 2000 Feb; 6(2):5. PubMed ID: 10734824
    [No Abstract]   [Full Text] [Related]  

  • 33. Minocycline-related cutaneous hyperpigmentation as demonstrated by light microscopy, electron microscopy and X-ray energy spectroscopy.
    Argenyi ZB; Finelli L; Bergfeld WF; Tuthill RJ; McMahon JT; Ratz JL; Petroff N
    J Cutan Pathol; 1987 Jun; 14(3):176-80. PubMed ID: 3611461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatic failure associated with imipramine therapy.
    Ilan Y; Samuel D; Reynes M; Tur-Kaspa R
    Pharmacopsychiatry; 1996 Mar; 29(2):79-80. PubMed ID: 8741026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypomelanosis due to block of melanosomal maturation in amiodarone-induced hyperpigmentation.
    Haas N; Schadendorf D; Hermes B; Henz BM
    Arch Dermatol; 2001 Apr; 137(4):513-4. PubMed ID: 11295949
    [No Abstract]   [Full Text] [Related]  

  • 36. Desipramine-induced blue-gray photosensitive pigmentation.
    Narurkar V; Smoller BR; Hu CH; Bauer EA
    Arch Dermatol; 1993 Apr; 129(4):474-6. PubMed ID: 8466219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluctuation of symptoms and social functioning in panic disorder with or without concomitant depression. A 5-year prospective follow-up.
    Albus M; Scheibe G; Scherer J
    Psychopathology; 1995; 28(5):229-34. PubMed ID: 8559945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Death of two subjects due to imipramine and desipramine metabolite accumulation during chronic therapy: a review of the literature and possible mechanisms.
    Swanson JR; Jones GR; Krasselt W; Denmark LN; Ratti F
    J Forensic Sci; 1997 Mar; 42(2):335-9. PubMed ID: 9068197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mucocutaneous Hyperpigmentation in a Patient With a History of Both Minocycline and Silver Ingestion.
    Fernandez-Flores A; Nguyen T; Cassarino DS
    Am J Dermatopathol; 2017 Dec; 39(12):916-919. PubMed ID: 28475520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of imipramine, fluvoxamine and depressive mood on autonomic cardiac functioning in major depressive disorder.
    Volkers AC; Tulen JH; van den Broek WW; Bruyn JA; Passchier J; Pepplinkhuizen L
    Pharmacopsychiatry; 2004 Jan; 37(1):18-25. PubMed ID: 14750044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.